Medi-K completed the 2024 Incentive Plan Restricted Stock Reservation Registration.

On September 25, 2025, Hangzhou Medikai Optoelectronic Technology Co., Ltd. completed the registration of the first class of restricted stock reserved for the 2024 stock option and restricted stock incentive plan. The reservation grant date was September 10, 2025, with a grant amount of 1.8745 million shares, granted to 50 people at a price of 3.69 yuan per share, sourced from the directed issuance of the company's A shares. The incentive plan has a maximum validity period of 60 months, with lock-up periods of 12 months and 24 months, with two phases of lock-up release, each releasing 50%. After this grant is completed, the total number of company shares will increase to 408,591,198 shares, with no change in the controlling shareholder and ultimate controller. Preliminary estimates indicate that the amortization of the incentive plan expenses will have a negligible impact on net profits in each year, and considering the positive effects, performance improvement will exceed the increase in expenses.